Brooklyn, NY, United States of America

Andrew Wasmuth

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 65(Granted Patents)


Location History:

  • New York, NY (US) (2014 - 2021)
  • Brooklyn, NY (US) (2015 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: **The Innovations of Andrew Wasmuth: A Focus on Patents and Collaborations**

Introduction

Andrew Wasmuth, an accomplished inventor based in Brooklyn, NY, has made significant contributions to the fields of pharmaceuticals and medicinal chemistry. With a portfolio of 16 patents, he has demonstrated a strong commitment to innovation and improving healthcare through his extensive research and development efforts.

Latest Patents

Andrew Wasmuth's latest patents highlight his expertise in the development of novel compounds. One of his prominent inventions, titled "Triazolopyrimidines, their preparation and use," provides a unique compound structure that holds potential therapeutic applications. The compound comprises various elements, allowing for a wide range of substitutions that could lead to significant advancements in medicine.

Another noteworthy patent is related to "Aldose reductase inhibitors and methods of use thereof." This invention focuses on novel compounds and pharmaceutical compositions aimed at promoting healthy aging and treating various health disorders. These disorders include skin, cardiovascular, renal, and angiogenesis conditions, as well as complications arising from diabetes. The comprehensive scope of this patent underscores the potential impact of his work on a multitude of health issues.

Career Highlights

Throughout his career, Wasmuth has worked with prestigious institutions, including Columbia University and the Albert Einstein College of Medicine. His experience in these environments has allowed him to cultivate his research capabilities and translate groundbreaking ideas into practical applications.

Collaborations

Collaboration has been a key component of Andrew Wasmuth's success. He has had the opportunity to work alongside esteemed colleagues such as Donald W. Landry and Banavara L. Mylari, who have also contributed valuable insights to the field of pharmaceutical research. These collaborations have enriched his work, leading to innovative solutions and advancements in medicine.

Conclusion

Andrew Wasmuth represents the spirit of innovation in the realm of pharmaceuticals. His extensive patent portfolio speaks to his dedication to developing new treatments and therapies that address critical health challenges. As his career progresses, the impact of his work will undoubtedly continue to resonate in the fields of health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…